Drug Catalog - Product Detail
DICLOFENAC SODIUM 3% GEL 100GM
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 71085-0003-00 | IPG PHARMACEUTICALS | 100 | 3% | GEL |
PACKAGE FILES
Generic Name
DICLOFENAC SODIUM
Substance Name
DICLOFENAC SODIUM
Product Type
HUMAN PRESCRIPTION DRUG
Route
TOPICAL
Application Number
ANDA206298
Description
DESCRIPTION Diclofenac Sodium Gel, 3%, contains the active ingredient, diclofenac sodium, in a clear, transparent, colorless to slightly yellow gel base. Diclofenac sodium is a white to slightly yellow crystalline powder. It is freely soluble in methanol, soluble in ethanol, sparingly soluble in water, slightly soluble in acetone, and partially insoluble in ether. The chemical name for diclofenac sodium is: Sodium [ o -(2,6-dichloranilino) phenyl] acetate Diclofenac sodium has a molecular weight of 318.13. The CAS number is CAS-15307-79-6. The structural formula is represented below: Diclofenac Sodium Gel, 3% also contains benzyl alcohol, hyaluronate sodium, polyethylene glycol monomethyl ether, and purified water. 1 g of Diclofenac Sodium Gel contains 30 mg of the active substance, diclofenac sodium. Chemical Structure
How Supplied
HOW SUPPLIED Diclofenac Sodium Gel, 3% is available in 100 g (NDC 71085-003-00) tubes. Each gram of gel contains 30 mg of diclofenac sodium. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from heat. Avoid freezing.
Indications & Usage
INDICATIONS AND USAGE Diclofenac Sodium Gel is indicated for the topical treatment of actinic keratoses (AK). Sun avoidance is indicated during therapy.
Dosage and Administration
DOSAGE AND ADMINISTRATION Diclofenac sodium gel is applied to lesion areas twice daily. It is to be smoothed onto the affected skin gently. The amount needed depends upon the size of the lesion site. Assure that enough diclofenac sodium gel is applied to adequately cover each lesion. Normally 0.5 g of gel is used on each 5 cm × 5 cm lesion site. The recommended duration of therapy is from 60 days to 90 days. Complete healing of the lesion(s) or optimal therapeutic effect may not be evident for up to 30 days following cessation of therapy. Lesions that do not respond to therapy should be carefully re-evaluated and management reconsidered.